Pregabalin and Speech Pathology Treatment for Refractory Chronic Cough with Laryngeal Hypersensitivity

治疗无效的持续性咳嗽会让患者虚弱和沮丧，对澳大利亚政府来说也是非常昂贵的。这项研究将提供一种新的有效的治疗方案，并扩大我们目前在识别和治疗难治性慢性咳嗽方面的世界领先地位。这一治疗策略以前从未进行过试验，这一发现将改变目前的医疗实践，并显着降低社区卫生成本。

Persistent cough that does not respond to medical treatment is debilitating and frustrating for the sufferer and very expensive for the Australian government. This research will provide a new and effective treatment option and extend our current reputation as the world leader in the identification and treatment of refractory chronic cough. This treatment strategy has not been trialled before and the findings will change current medical practice and significantly reduce community health costs.